BETTEN-AID SIMPLE HEARTBURN RELIEF
  • Your heartburn meds are killing you!
    • Top 5 Reasons Never to Take a Proton Pump Inhibitor
    • Heartburn Meds Tied to Higher Diabetes Risk
    • Use of proton pump inhibitors and risk of adverse clinical outcomes from COVID‐19: a meta‐analysis
    • Reflux Drugs Tied to Bone Fractures in Children
    • Heartburn drugs linked to fatal heart and kidney disease, stomach cancer
    • Millions of Canadians using acid-reflux drugs for too long, risking health side-effects
    • Using friendly bacteria to treat Irritable Bowel Syndrome
    • Proton Pump Inhibitors: How to Deprescribe These Nutrient Robbers
    • Pneumonia Risk with PPI Use Continues Past One Year, Researchers Say
    • Acidity and Heartburn Medications May Up Risk Of Pneumonia In The Elderly
    • Babies Given Antibiotics or Antacids May Be More Likely to Have Allergies, Study Finds
    • Study Links Popular Heartburn Drugs to Esophageal Cancer
    • The Purple Pill in the Red Zone
    • PPIs Linked to Pancreatic Cancer, Death
    • Guidelines for Limiting Unnecessary Use of Proton Pump Inhibitors
    • Superbug’ may depend on calcium to multiply
    • Some heartburn drugs linked with higher risk of death
    • Probiotics, Enzymes to Support Gut Health
    • Infants prescribed antacids for reflux have increased risk of bone fractures
    • How reflux drugs could raise fracture risk in babies
    • Heartburn Meds: Do They Do More Harm Than Good?
    • Day after Super Bowl, 16 million stay home on 'Super Sick Day'
    • Heartburn Medication Linked to Increased Risk of First Time Stroke
    • The Use Of Common Drugs For Heartburn Now Linked To Developing Stroke, Study Finds
    • Could common heartburn drugs increase stroke risk?
    • Stomach Flu More Common in PPI Users
    • Proton Pump Inhibitors May Reduce Efficacy of Capecitabine
    • Do This One Easy Thing If You Want Garbage In Your Cells
    • Proton Pump Inhibitor Lawsuits Mount
    • Study: PPI Acid Reflux Drugs Overused in People with GI Bleeds
    • PPI Heartburn Drugs Linked to Brain Problems, Fluid Build Up
    • Should you be taking stomach-acid reducers?
    • Dementia
    • Mental Health >
      • One-third of US adults may unknowingly use medications that can cause depression
      • Stomach acid drugs may cause depression
    • Heart Disease >
      • Giving PPIs and Antibiotics Together May Disrupt Heart Rhythm
      • Study Shows Heartburn Drugs Increase Risk of Cardiovascular Complications
    • Increased Infections >
      • AH-CHOO! THESE MEDS LINKED WITH HIGHER ALLERGY RISK IN KIDS
      • Acid Suppression Drugs Linked to Gastrointestinal Infections
      • PPIs increase risk for hepatic encephalopathy, spontaneous bacterial peritonitis
    • Kidney Failure >
      • ASN: PPIs associated with increased risk of kidney disease
      • Proton Pump Inhibitors May Increase Risk for Kidney Disease
      • Proton Pump Inhibitor Drugs Linked To Silent Kidney Damage
      • Popular OTC Acid Reflux Medicines May Carry Substantial Negative Side Effects, Studies Show
    • Osteoporosis >
      • New Concerns over Suspected Link Between Nexium and Osteoporosis
  • What is Betten-Aid?
    • Tummy Trouble Is On The Rise Among Americans, Gastrointestinal Experts Say
  • Store
  • A new Paradigm in Acid Reflux.
  • Natural vs. Synthetic
  • National group wants cancer warning labels on acid reflux drugs

Study Shows Heartburn Drugs Increase Risk of Cardiovascular Complications

Picture
Posted by Roopal Luhana
August 18, 2016 2:19 PM

​
Proton pump inhibitors (PPIs) like Prilosec and Nexium have already been linked to a number of health problems, including chronic kidney disease (CKD), bone fractures, and dependency.
Now, according to a new study, they may also lead to complications in patients with heart disease. The study was published June 2016 in the scientific journal, International Journal of Cardiology.
Study Shows PPIs Worsen Profiles for Patients with Cardiovascular DiseaseFor the study, researchers observed over 600 patients with heart disease. About half had been using PPIs after cardiovascular treatment. These included drugs like Prevacid, Nexium, and Prilosec, all taken as part of the therapy the patients were going through. Those who were dealing with atrial fibrillation were more likely to be using the drugs than others.
Results showed that those patients taking PPIs were six times more likely to suffer from anemia—a deficiency of red blood cells—than those who didn’t take the drugs. The use of the drugs was also associated with a worsening metabolic profile—a broad screening that evaluates blood sugar and cholesterol levels, electrolyte and fluid balances, kidney function and liver function. The researchers believed that this result could be partially to blame on the decreased use in this group of ACE-inhibitors (which reduce blood pressure) and statins (which reduce blood cholesterol).
In conclusion, the researchers stated that prolonged use of PPIs in these patients was linked with worsening of red blood count indexes, lower weight and underutilization of cardioprotective drugs (like statins and blood pressure drugs).
Study Shows PPIs Accelerate Vascular AgingThere has been concern in the past that PPIs may be connected with poor cardiovascular outcomes. In 2015, for example, two studies appearing in PLoS One reported that PPIs could actually increase risk of heart attack by 21 percent, and that those who had a heart attack while taking the drugs were two times more likely to die.
According to a Medical News Today report on the study, “Proton pump inhibitors (PPIs) appear to have a negative effect on vascular function, thereby increasing the risk for myocardial infarction (MI) in the general public.”
Another study published in May 2016 suggested a possible reason why these drugs may negatively affect vascular function. Researchers found that vascular cells exposed to PPIs for long periods built up cellular garbage in the linings of the cells, accelerating blood vessel aging. The cells exposed to the drugs had a “fried egg” look according to the scientists. Those exposed to an alternative heartburn type of drug, though, called an “H2 blocker,” did not show the same degenerative effect.
“I’m perplexed that the pharmaceutical industry didn’t run across this first,” senior study author John P. Cooke told Fox News. “This is something that should have been apparent a long time ago and should have been investigated.”
Researchers concluded that patients and doctors should think twice before using these drugs long-term. Currently, the FDA suggests only short-term use for stomach ulcers and gastroesophageal reflux disease (GERD).
The Pharmaceutical Journal states that some 113 million prescriptions are dispensed worldwide for these rugs each year, and that about 21 million in the U.S. used one or more of them in 2009.

Comment:
Once again we didn't need lawyers to tell us how bad  heartburn drugs are.  Unless that lawyer was Dr. Eisenstein.

Powered by Create your own unique website with customizable templates.